11 /15
Make a 2024 Plan for Weight Loss and Diabetes Medications
Join Accolade to learn how physician leaders within our organization could provide clinical guidance on bringing GLP-1s into your organization...
Watch nowJoin Accolade to learn how physician leaders within our organization could provide clinical guidance on bringing GLP-1s into your organization
If you are among the 43% of employers considering coverage of GLP-1s for weight loss like Wegovy and diabetes medication, Ozempic, next year, you need a strategy for rolling them out to your workforce. Who should qualify for coverage? How can you monitor safe and effective use? Will you need to adjust your population health targets? Panelists:
- Connie Hwang, MD, Chief Medical Officer, Accolade
- James Wantuck, MD, Associate Chief Medical Officer, Accolade. Co-founder, PlushCare
Moderator:
- Katie Miller Blakemore, Senior Manager, Events, Accolade
Obtain perspective on the true cost of chronic conditions like diabetes and obesity.
Understand primary care’s critical role in a holistic care approach and the safe prescription of medications.
Learn the key considerations primary care physicians use to diagnose diabetes and obesity and decide if GLP-1s would be a helpful medication.
How to appropriately set goals and expectations beyond the medication when it comes to a patient-centered support model.
Join Accolade to learn how physician leaders within our organization could provide clinical guidance on bringing GLP-1s into your organization...
Watch nowHear how Rx Savings Solutions educates consumers through price transparency and helps them fully utilize their plan benefits while also supporting broader health initiatives...
Watch nowWhy struggle in the labyrinth of healthcare when you can confidently lead the way? With Accolade, you’re not just buying a solution; you’re investing in a brighter, healthier future for your employees and their families...
Watch now